Home » Topics » Regulatory » Patents

Patents
RSS

Istituto Europeo di Oncologia describes novel KDM4C inhibitors

Dec. 4, 2017

Enanta Pharmaceuticals presents novel farnesoid X receptor agonists

Dec. 4, 2017

Prolyl endopeptidase inhibitors identified at Bayer

Dec. 4, 2017

New proteolysis targeting chimera compounds presented by C4 Therapeutics

Dec. 4, 2017

Femtogenix synthesizes novel anticancer conjugate compounds

Dec. 4, 2017

Enanta patents novel farnesoid X receptor agonists

Dec. 1, 2017

Novel AMP-activated protein kinase activators generated at Shionogi

Dec. 1, 2017

Luoda Biosciences and Nanjing Shiqi Pharmaceutical describe novel anticancer compounds

Dec. 1, 2017

Zhejiang Hisun Pharmaceutical presents new epothilone derivatives

Dec. 1, 2017

Istituto Europeo di Oncologia Srl synthesizes new lysine-specific demethylase 4C inhiibitors

Nov. 30, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...